As the U.S. backpedals on its mRNA investment, Mexico is embracing the technology through a new manufacturing pact with ...
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results